Laxxon Medical | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Laxxon Medical

BRIEF

published on 10/29/2024 at 16:15, 22 days 21 hours ago

Laxxon Medical Appoints Lauren Chung as Chief Financial Officer

Chief Financial Officer Healthcare Industry Strategic Growth Laxxon Medical Lauren Chung
PRESS RELEASE

published on 10/29/2024 at 16:10, 22 days 21 hours ago

Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer
Laxxon Medical appoints Lauren Chung PhD MBA as Chief Financial Officer, signaling strategic expansion. Dr. Chung brings over 2 decades of healthcare industry experience and will enhance financial and operational management capabilities

Chief Financial Officer Financial Management Healthcare Industry Laxxon Medical Lauren Chung
BRIEF

published on 10/25/2024 at 17:05, 26 days 21 hours ago

Laxxon Medical to Host Fireside Chat at UBS Healthcare Conference

Healthcare Industry Fireside Chat Drug Delivery Laxxon Medical UBS Conference
PRESS RELEASE

published on 10/25/2024 at 17:00, 26 days 21 hours ago

Laxxon Medical to Host a Fireside Chat at UBS Global Healthcare Conference
Laxxon Medical to host a fireside chat at UBS Global Healthcare Conference on Nov 14, 2024. The chat will include key executives discussing pharmaceutical technology innovations

Innovations Fireside Chat Laxxon Medical Pharmaceutical Technology UBS Global Healthcare Conference
BRIEF

published on 10/14/2024 at 16:05, 1 month 6 days ago

Laxxon Medical Unveils Oral GLP-1 Agonist at BIO Europe 2024

3D Printing Technology Pharmaceutical Innovation Oral GLP-1 Agonist Patient Compliance Weight Loss Treatment
PRESS RELEASE

published on 10/14/2024 at 16:00, 1 month 6 days ago

Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
Laxxon Medical to showcase innovative oral GLP-1 Agonist micro-tablet at 2024 BIO Europe Convention, aiming to enhance patient compliance. Event aims to discover new partnerships

Laxxon Medical Oral GLP-1 Agonist Patient Compliance Micro-tablet BIO Europe Convention
BRIEF

published on 10/09/2024 at 20:06, 1 month 11 days ago

Laxxon Medical to Present SPID® Technology at CPHI Milan 2024

Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
PRESS RELEASE

published on 10/09/2024 at 20:01, 1 month 11 days ago

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology

Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF

published on 10/01/2024 at 15:05, 1 month 19 days ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE

published on 10/01/2024 at 15:00, 1 month 19 days ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities

Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP

Accesswire

Published on 11/21/2024 at 13:30, 36 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 36 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 6 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 51 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 31 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 51 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 6 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 46 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 21 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE